Your support fuels our research to #EndALS! Donate Now


TDI 163

Scientists at the ALS Therapy Development Institute are conducting research on this small molecule to determine if it can be an effective treatment for ALS by addressing the hyperexcitability of motor neurons of PALS.


Type: Small Molecule
Stage: Preclinical
Status: Active
Sponsor: ALS Therapy Development Institute

TDI Says:

We are currently conducting pharmacokinetic and pharmacodynamic experiments to determine an appropriate dosing stratagem to move this project into later stage preclinical testing, such as survival efficacy screening.

Comment on this Topic

(All comments are moderated before they appear here.)